Calif. Pay-For-Delay Ban Won't Be Paused Pending Appeal
Law360 (January 10, 2020, 9:49 PM EST) -- A California federal judge on Friday declined to temporarily block a new state law prohibiting pay-for-delay deals between branded and generic drug makers while a group of pharmaceutical companies appeals his earlier decision, ruling the group hadn't shown a likelihood of success in the Ninth Circuit.
Assembly Bill 824 is a 2019 law that establishes a presumption of anti-competitiveness for reverse payment settlements in which a generic-drug maker postpones market entry and receives a payment from the branded competitor.
Last week, the Association for Accessible Medicines said it appealed to the Ninth Circuit following U.S. District Judge Troy L. Nunley's New Year's...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!